BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24382837)

  • 21. Clinical and pathological analyses of transplant glomerulopathy cases.
    Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection.
    Pearl MH; Nayak AB; Ettenger RB; Puliyanda D; Palma Diaz MF; Zhang Q; Reed EF; Tsai EW
    Pediatr Nephrol; 2016 Aug; 31(8):1341-8. PubMed ID: 27048228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.
    Musat AI; Agni RM; Wai PY; Pirsch JD; Lorentzen DF; Powell A; Leverson GE; Bellingham JM; Fernandez LA; Foley DP; Mezrich JD; D'Alessandro AM; Lucey MR
    Am J Transplant; 2011 Mar; 11(3):500-10. PubMed ID: 21342448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure.
    Malheiro J; Santos S; Tafulo S; Dias L; Martins S; Fonseca I; Almeida M; Pedroso S; Beirão I; Castro-Henriques A; Cabrita A
    Transplantation; 2018 Nov; 102(11):1943-1954. PubMed ID: 29757900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C4d detection and histological patterns in the diagnosis of antibody-mediated rejection after lung transplantation: a single-centre study.
    Ngo C; Danel C; Duong-Quy S; Dauriat G; Castier Y; Lortat-Jacob B; Mal H; Brugière O; Cazes A
    Histopathology; 2019 Jun; 74(7):988-996. PubMed ID: 30636056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of Circulating Complement-Fixing Donor-Specific Antibodies Identified by the C1q Assay and Presence of C4d in Endomyocardial Biopsy Specimens.
    Frank R; Lal P; Kearns J; Molina MR; Wald JW; Goldberg LR; Kamoun M
    Am J Clin Pathol; 2016 Jan; 145(1):62-8. PubMed ID: 26712872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies.
    Kozlowski T; Rubinas T; Nickeleit V; Woosley J; Schmitz J; Collins D; Hayashi P; Passannante A; Andreoni K
    Liver Transpl; 2011 Apr; 17(4):357-68. PubMed ID: 21445918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute Antibody-mediated rejection in liver transplantation: Impact and applicability of the Banff working group on liver allograft pathology 2016 criteria.
    Maurice JB; Nwaogu A; Gouda M; Shaw O; Sanchez-Fueyo A; Zen Y
    Hum Pathol; 2022 Sep; 127():67-77. PubMed ID: 35728694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
    Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic Characteristics of Late Acute Antibody-mediated Rejection in Pediatric Liver Transplantation.
    Zhou S; Mitsinikos T; Emamaullee J; Weaver C; Wang L; Shillingford N; Warren M; Bawab JH; Tiwari N; Genyk Y; Thomas D; Parham DM
    Transplantation; 2021 Sep; 105(9):2045-2053. PubMed ID: 33031223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute Cellular Rejection and C4d Positivity in Heart Transplantation : A Manifestation of Asymptomatic Antibody-Mediated Rejection?
    Mohamedali B; Pyle J; Bhat G
    Am J Clin Pathol; 2016 Feb; 145(2):238-43. PubMed ID: 26767383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study.
    Moktefi A; Parisot J; Desvaux D; Canoui-Poitrine F; Brocheriou I; Peltier J; Audard V; Kofman T; Suberbielle C; Lang P; Rondeau E; Grimbert P; Matignon M
    Transpl Int; 2017 Mar; 30(3):277-287. PubMed ID: 27992962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody-mediated rejection in pediatric liver transplant recipients.
    Markiewicz-Kijewska M; Kaliciński P; Kluge P; Piątosa B; Rękawek A; Jankowska I; Kostecka E; Kurowski PN
    Ann Transplant; 2014 Mar; 19():119-23. PubMed ID: 24594760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological characterization of chronic antibody-mediated rejection in ABO-identical or ABO-compatible pediatric liver graft recipients.
    Dao M; Habès D; Taupin JL; Mussini C; Redon MJ; Suberbielle C; Jacquemin E; Gonzales E; Guettier C
    Liver Transpl; 2018 Jul; 24(7):897-907. PubMed ID: 29704327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular deposition of complement C4d is increased in liver allografts with chronic rejection.
    Martelius T; Halme L; Arola J; Höckerstedt K; Lautenschlager I
    Transpl Immunol; 2009 Sep; 21(4):244-6. PubMed ID: 19540918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphologic and immunophenotypic evaluation of liver allograft biopsies with contemporaneous serum DSA measurements.
    El Hag MI; Kaneku H; Jorgensen D; Zeevi A; Stevenson HL; Yadak N; Hassan M; Du X; Demetris AJ
    Clin Transplant; 2023 Aug; 37(8):e14997. PubMed ID: 37096730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients.
    Wahrmann M; Bartel G; Exner M; Regele H; Körmöczi GF; Fischer GF; Böhmig GA
    Transpl Int; 2009 Oct; 22(10):982-9. PubMed ID: 19619171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy.
    Frank R; Molina MR; Goldberg LR; Wald JW; Kamoun M; Lal P
    Am J Clin Pathol; 2014 Dec; 142(6):809-15. PubMed ID: 25389335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.